Yuya Terashima
ORCID: 0000-0003-3127-367X
· 1 paper in corpus
Serum samples from patients with benign or malignant diseases were measured for the newly developed tumor markers CA54/61 and CA602 with the respective EIA kits for assessment of their utility as tumor markers. A total of 5236 patients were…